These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. Coleman I; Ruiz G; Brahmbhatt S; Ackerman L J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853 [TBL] [Abstract][Full Text] [Related]
44. Scaling Down to Scale Up: A Health Economic Analysis of Integrating Point-of-Care Syphilis Testing into Antenatal Care in Zambia during Pilot and National Rollout Implementation. Shelley KD; Ansbro ÉM; Ncube AT; Sweeney S; Fleischer C; Tembo Mumba G; Gill MM; Strasser S; Peeling RW; Terris-Prestholt F PLoS One; 2015; 10(5):e0125675. PubMed ID: 25970443 [TBL] [Abstract][Full Text] [Related]
45. Impact of Xpert MTB/RIF rollout on management of tuberculosis in a South African community. Schmidt BM; Geldenhuys H; Tameris M; Luabeya A; Mulenga H; Bunyasi E; Scriba T; Hatherill M S Afr Med J; 2017 Nov; 107(12):1078-1081. PubMed ID: 29262960 [TBL] [Abstract][Full Text] [Related]
46. First case of Stevens-Johnson syndrome after rabies vaccination. Ma L; Du X; Dong Y; Peng L; Han X; Lyu J; Bai H Br J Clin Pharmacol; 2018 Apr; 84(4):803-805. PubMed ID: 29333656 [TBL] [Abstract][Full Text] [Related]
47. Analysis of DNA from subjects found to be heterozygous for the haptoglobin-Johnson alpha gene. Nagai T; Okazaki T; Yanagisawa Y Exp Clin Immunogenet; 1997; 14(2):113-7. PubMed ID: 9395886 [TBL] [Abstract][Full Text] [Related]
48. US opioids: Johnson and Johnson and drug distributors offer $26bn to end thousands of lawsuits. Dyer O BMJ; 2021 Jul; 374():n1867. PubMed ID: 34301636 [No Abstract] [Full Text] [Related]
49. Johnson & Johnson "regrets" 1971 study that injected asbestos into US prisoners. Dyer O BMJ; 2022 Mar; 376():o681. PubMed ID: 35292435 [No Abstract] [Full Text] [Related]
50. Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021. Shay DK; Gee J; Su JR; Myers TR; Marquez P; Liu R; Zhang B; Licata C; Clark TA; Shimabukuro TT MMWR Morb Mortal Wkly Rep; 2021 May; 70(18):680-684. PubMed ID: 33956784 [TBL] [Abstract][Full Text] [Related]
51. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723 [TBL] [Abstract][Full Text] [Related]
52. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487 [TBL] [Abstract][Full Text] [Related]
53. Covid-19: Booster vaccine to be rolled out in autumn as UK secures 60m more Pfizer doses. Mahase E BMJ; 2021 Apr; 373():n1116. PubMed ID: 33926905 [No Abstract] [Full Text] [Related]
54. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. Wolf ME; Luz B; Niehaus L; Bhogal P; Bäzner H; Henkes H J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33918932 [TBL] [Abstract][Full Text] [Related]
55. Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2021 Apr; 384(17):e77. PubMed ID: 33913647 [No Abstract] [Full Text] [Related]
56. Covid-19: One dose of vaccine cuts risk of passing on infection by as much as 50%, research shows. Mahase E BMJ; 2021 Apr; 373():n1112. PubMed ID: 33910890 [No Abstract] [Full Text] [Related]
57. Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures. Goldfarb JL; Kreps S; Brownstein JS; Kriner DL N Engl J Med; 2021 Jul; 385(2):101-103. PubMed ID: 33909962 [No Abstract] [Full Text] [Related]
58. Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19. Kuehn BM JAMA; 2021 Apr; 325(16):1603. PubMed ID: 33904859 [No Abstract] [Full Text] [Related]
59. The Coming of Age of Nucleic Acid Vaccines during COVID-19. Rando HM; Lordan R; Kolla L; Sell E; Lee AJ; Wellhausen N; Naik A; Kamil JP; ArXiv; 2023 Jan; ():. PubMed ID: 36263086 [TBL] [Abstract][Full Text] [Related]
60. Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK. Ibrahim D; Kis Z; Tak K; Papathanasiou MM; Kontoravdi C; Chachuat B; Shah N Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]